CopyFind
medicine 📍 UA

ІНСПРА

Analogs of ІНСПРА

Find cheaper analogs and generic equivalents for ІНСПРА.

Ingredients

ਸਰਗਰਮ ਤੱਤ: Eplerenone


ਉਤਪਾਦ ਝਲਕ

About INSPRA

INSPRA - this medicinal product, which is used for reduction RYZYKU ZAKhVORIuVANOSTI and LETALNOSTI, POV'IaZANYKh IZ SERTsEVO-SUDYNNYMY ZAKhVORIuVANNIaMY in PATsIIeNTIV with dysfunction left ventricle and KLINIChNYMY OZNAKAMY SERTsEVOI insufficiency after INFARKTU MIOKARDA.

INSPRA also is used for reduction RYZYKU ZAKhVORIuVANOSTI and LETALNOSTI, POV'IaZANYKh IZ SERTsEVO-SUDYNNYMY ZAKhVORIuVANNIaMY, in PATsIIeNTIV IZ SERTsEVOIu NEDOSTATNISTIu II class ZA KLASYFIKATsIIeIu NYHA and dysfunction left ventricle.

Composition

The composition of INSPRA contains active substance EPLERENON in DOZI 25 mg or 50 mg on ODNU TABLETKU. Excipients include LAKTOZU, monohydrate, microcrystalline cellulose, sodium KROSKARMELOZU, HIPROMELOZU, sodium LAURYLSULFAT, talc, magnesium stearate and Opadry ZhOVTYI YS-1–12524-A.

Indications

INSPRA is used for DOPOVNENNIa STANDARTNOHO treatment IZ ZASTOSUVANNIaM β-BLOKATORIV in PATsIIeNTIV with dysfunction left ventricle and KLINIChNYMY OZNAKAMY SERTsEVOI insufficiency after INFARKTU MIOKARDA.

Also INSPRA is used for DOPOVNENNIa STANDARTNOI OPTYMALNOI therapy in PATsIIeNTIV IZ SERTsEVOIu NEDOSTATNISTIu II class ZA KLASYFIKATsIIeIu NYHA and dysfunction left ventricle.

Pharmacological properties

EPLERENON MAIe VIDNOSNU SELEKTYVNIST in ZV'IaZUVANNI with REKOMBINANTNYMY RETsEPTORAMY human to MINERALOKORTYKOIDIV PORIVNIaNO with its VZAIeMODIIeIu with REKOMBINANTNYMY RETsEPTORAMY human to HLIuKOKORTYKOIDIV, PROHESTERONU and ANDROHENIV.

EPLERENON PEREShKODZhAIe ZV'IaZUVANNIu receptors with ALDOSTERONOM, which BERE UChAST in REHULIuVANNI ARTERIALNOHO TYSKU and ZADIIaNYI in PATOFIZIOLOHIChNYKh MEKhANIZMAKh development SERTsEVO-SUDYNNYKh diseases.

Source: Compendium

Find in Pharmacies

Compare local prices and distance for ІНСПРА.

Visitor ratings

Help others by rating how useful this product page is.

No ratings yet — be the first.